Optomed Oyj (OPTOMED.HE)
EUR 3.95
(3.27%)
EUR 3.95
(3.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.26 Million EUR | -26.9% |
| 2022 | -1.78 Million EUR | -224.81% |
| 2021 | 1.42 Million EUR | 149.5% |
| 2020 | -2.88 Million EUR | 63.16% |
| 2019 | -7.82 Million EUR | -183.9% |
| 2018 | 9.32 Million EUR | 82.1% |
| 2017 | 5.12 Million EUR | 136.15% |
| 2016 | 2.16 Million EUR | 138.09% |
| 2015 | 911 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.21 Million EUR | 46.24% |
| 2024 Q2 | -7.98 Million EUR | -557.12% |
| 2023 Q3 | -3.79 Million EUR | -1110.67% |
| 2023 Q4 | -2.26 Million EUR | 40.37% |
| 2023 Q1 | -758 Thousand EUR | 57.44% |
| 2023 Q2 | 375 Thousand EUR | 149.47% |
| 2023 FY | -2.26 Million EUR | -26.9% |
| 2022 Q4 | -1.78 Million EUR | -366.62% |
| 2022 Q2 | 220 Thousand EUR | -92.5% |
| 2022 FY | -1.78 Million EUR | -224.81% |
| 2022 Q3 | 668 Thousand EUR | 203.64% |
| 2022 Q1 | 2.93 Million EUR | 105.68% |
| 2021 Q4 | 1.42 Million EUR | 997.48% |
| 2021 FY | 1.42 Million EUR | 149.5% |
| 2021 Q3 | -159 Thousand EUR | 84.86% |
| 2021 Q1 | -2.32 Million EUR | 19.22% |
| 2021 Q2 | -1.05 Million EUR | 54.92% |
| 2020 FY | -2.88 Million EUR | 63.16% |
| 2020 Q2 | -4.25 Million EUR | 6.65% |
| 2020 Q3 | -3.56 Million EUR | 16.16% |
| 2020 Q4 | -2.88 Million EUR | 19.09% |
| 2020 Q1 | -4.55 Million EUR | 41.81% |
| 2019 Q1 | 2 Million EUR | -78.56% |
| 2019 FY | -7.82 Million EUR | -183.9% |
| 2019 Q4 | -7.82 Million EUR | -185.17% |
| 2019 Q3 | 9.18 Million EUR | 0.0% |
| 2018 Q4 | 9.32 Million EUR | 0.0% |
| 2018 FY | 9.32 Million EUR | 82.1% |
| 2017 FY | 5.12 Million EUR | 136.15% |
| 2016 FY | 2.16 Million EUR | 138.09% |
| 2015 FY | 911 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|